Weight loss in nintedanib-treated patients with idiopathic pulmonary fibrosis
Hiromi Tomioka, Masaaki Iwabayashi, Makoto Yokota, Rika Hashimoto, Hisanori Amimoto
Topics & Concepts
NintedanibMedicineIdiopathic pulmonary fibrosisInternal medicineWeight lossAdverse effectBody mass indexCommon Terminology Criteria for Adverse EventsConfidence intervalGastroenterologyOdds ratioSurgeryObesityLungInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchOccupational exposure and asthma